RT Journal Article
SR Electronic
T1 Recent update on COVID-19 in India: Is locking down the country enough?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.06.20053124
DO 10.1101/2020.04.06.20053124
A1 Virk, Jitender Singh
A1 Ali, Syed Azmal
A1 Kaur, Gurjeet
YR 2020
UL http://medrxiv.org/content/early/2020/04/10/2020.04.06.20053124.abstract
AB India is the second-largest population in the world, and developing nation, it is not well equipped as compared to other developed countries like China, USA, Italy, Germany. Hitherto, in the scenario of the global pandemic, SARS-CoV-2 affected a hundred thousand people in 202 countries and territories, which could impart a devastating impact on the Indian population. In the absence of vaccines, the only way to respond against this critical condition is by practicing large-scale social distancing. Interestingly, China diminishes COVID-19 cases by forcefully applying strict restrictions to isolate even mild symptomatic individuals; local authorities went door to door for testing, increases the hospital facilities, including ventilators. Likewise, India also took a very bold decision to lock down the whole country for 21 days, starting from 24 March 2020 after detecting 571 positive COVID-19 confirmed cases. However, till 1 April 2020, SARS-CoV-2 positive cases were growing exponentially, which raises the concerns if the number of reported and actual cases are similar. Our analysis suggests that there is an urgent need to take action to extend the period of lockdown and allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. Otherwise, the outbreak in India can reach the level of the USA or Italy or could be worse than these countries within a few days or weeks, given the size of the population and lack of resources.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectorsAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is found within the manuscript or publicly available through the cited web sources